ClinicalTrials.gg
Not yet recruitingNCT07891689Updated Oct 23, 2026

Explainable AI for Prospective Pressure Injury Staging

An observational study in Pressure Injury, sponsored by hatice akaltun. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-23.

Sponsored by hatice akaltun · Observational

Updated Oct 23, 2026Newly registeredGo to Updates ↓
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
415
Ages
18 Years and older
Sex
All
01

Study summary

This prospective observational mixed-methods study aims to develop and evaluate an explainable artificial intelligence model for staging pressure injuries using standardized clinical photographs and expert panel-labeled images from adult patients. The study will also explore nurses' views on the clinical acceptability and usability of the decision-support system through semi-structured interviews.

02

Conditions studied

  • Pressure Injury

Browse trials for

Keywords

  • Pressure injury staging
  • Explainable artificial intelligence
  • Machine learning
  • Clinical decision support
  • nurses
03

In context

Pressure Ulcer

526 studies on the registry are indexed under Pressure Ulcer; 120 are open to participants now.

This study's planned enrollment of 415 is above the median of 155 across 98 observational studies indexed under Pressure Ulcer.

Browse Pressure Ulcer studies →

Lead sponsor

hatice akaltun is the lead sponsor of 3 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study population will consist of adults aged 18 years or older with at least one pressure injury who are receiving care in the participating clinical units. Standardized clinical photographs and clinical data will be collected prospectively. In addition, approximately 10-15 nurses working in intensive care or surgical units and involved in pressure injury care will be invited to participate in individual semi-structured interviews. Patients and nurses will participate voluntarily after providing informed consent.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Adults aged 18 years or older.
  2. Patients with at least one pressure injury.
  3. Patients whose pressure injury can be photographed according to the study protocol.
  4. Patients or legally authorized representatives who provide informed consent.

    For the qualitative component:

  5. Nurses working in intensive care or surgical units.
  6. Nurses involved in pressure injury care.
  7. Nurses who provide informed consent and agree to participate in an individual semi-structured interview.

Exclusion criteria

Exclusion Criteria:

  1. Patients who do not provide informed consent.
  2. Patients whose clinical condition does not allow the photography procedure.
  3. Images that are technically inadequate or do not meet the study quality criteria.
  4. Nurses who do not provide informed consent.
  5. Nurses who are unable to complete the interview.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
415 participants (estimated)
Patient registry
No

Groups and cohorts

  • Adult Patients with Pressure Injuries

    Adult patients with pressure injuries whose standardized clinical photographs and clinical data will be collected prospectively. Pressure injuries will be independently staged by an expert panel, and the images will be used to develop and evaluate an explainable artificial intelligence model. No intervention will be administered.

  • Nurses Participating in Interviews

    Approximately 10-15 nurses working in intensive care and surgical units who provide pressure injury care will participate in individual semi-structured interviews. The interviews will explore their views on the clinical acceptability, usability, interpretability, and potential use of the explainable artificial intelligence decision-support system. No intervention will be administered.

06

What researchers measure

Primary outcomes

  1. Accuracy of the Explainable Artificial Intelligence Model in Pressure Injury Staging

    The proportion of pressure injury images correctly staged by the explainable artificial intelligence model compared with the reference staging determined by the expert panel. Accuracy will be calculated as the number of correctly classified images divided by the total number of evaluable images.

    Time frame: From completion of image collection through completion of data analysis, approximately 8 months

Secondary outcomes

  1. Nurses' Views on the Clinical Acceptability and Usability of the Explainable Artificial Intelligence Decision-Support System

    Nurses' views will be explored through individual semi-structured interviews. The interviews will be analyzed using thematic analysis to identify perceptions of clinical acceptability, usability, interpretability, potential benefits, concerns, and barriers to using the system.

    Time frame: From completion of nurse interviews through completion of qualitative data analysis, approximately 4 months

07

Study locations

1 site
  • Sbu. Van Education and Research Hospital
    Van, 65000, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No — Individual participant-level data will not be shared because the dataset includes sensitive clinical photographs and interview data. Although the data will be de-identified, sharing may pose a risk of re-identification. Only aggregated and anonymized results will be reported.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for Jun 2027, 7 months later.

Of 44 observational studies under Pressure Ulcer, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 141. This study's planned 7 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 18, 2026
First posted
Oct 23, 2026
StartEst.
Nov 2026
Primary completionEst.
Jun 2027
CompletionEst.
Oct 2027
Last update
Oct 23, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 23, 2026
Show all 1 update
  1. Oct 23, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07891689
Lead sponsor
hatice akaltun
Collaborators
Yuzuncu Yil University
Responsible party
hatice akaltun (lecturer dr, Yuzuncu Yil University) — Sponsor-investigator
First posted
Oct 23, 2026
Start date
Nov 2026 (estimated)
Primary completion
Jun 2027 (estimated)
Completion
Oct 2027 (estimated)
Last update
Oct 23, 2026

Study contacts

Hatice Akaltun, lecturer dr
Contact
haticeakaltun@yyu.edu.tr
0 (432) 444 50 65 ext. 21242

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion